Nefopam Teva (Nefopam Hydrochloride)

Nefopam Hydrochloride, the active ingredient in Nefopam Teva, is a non‑opioid analgesic presented as a parenteral solution for intramuscular and intravenous use. It is employed to manage moderate to severe acute pain, including post‑operative pain, in adult patients by acting centrally on pain pathways.

GNH USA supplies Nefopam Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Nefopam Teva is a centrally acting non‑opioid analgesic used for acute pain management.

- Moderate to severe acute pain: provides effective analgesia for sudden, intense pain episodes. - Post‑operative pain: reduces discomfort following surgical procedures. - Acute musculoskeletal pain: helps control pain after injuries or strain.

Nefopam Teva may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dry mouth: reduced salivation. - Sweating: increased perspiration. - Tachycardia: elevated heart rate. - Blurred vision: temporary visual disturbances. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Seizures: risk of convulsive episodes, especially at high doses. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, itching, or anaphylaxis. - Cardiac arrhythmia: irregular heart rhythm. - Agranulocytosis: rare blood cell deficiency. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before using Nefopam Teva, consider the following safety measures.

- Renal impairment: monitor kidney function and adjust therapy if needed. - Cardiovascular disease: observe heart rate and blood pressure closely. - History of seizures: use with caution due to seizure risk. - Pregnancy: safety not established; weigh benefits against potential risks. - Concomitant MAO inhibitors: avoid because of possible hypertensive crisis. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nefopam Teva can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - Serotonergic agents (e.g., SSRIs, SNRIs): increased risk of serotonin syndrome. - Tricyclic antidepressants: can amplify cardiovascular effects.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive hypotensive effect. - Anticholinergic drugs: may worsen dry mouth. - CYP450 inhibitors: potential increase in nefopam plasma concentrations.